Reduction of Masseter Muscle Prominence (MMP) After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period 1 in Japan

Toxicon 2026

View at publisher
Authors: Nobutaka Furuyama, Taro Kono, Akiko Imaizumi, Kiyoko Kato, Akihiro Kume, Mariko Kato, Takeshi Yoshikawa, Mana Hirayama, Rene M. Hopfinger, Catherine Foley, Reva McCaskill, Yoko Yajima
+2 more Chihaya Morioka, Yupu Wu
DOI: 10.1016/j.toxicon.2025.108750
Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Myofascial pain diagnosis and treatment Cardiovascular Syncope and Autonomic Disorders

Publication details

Journal / source
Toxicon
Volume
271
Pages
108750–108750
Publication date
8 January 2026
Language
EN